Clinical Trials in San Francisco

Showing 7681-7700 of 12,991 trials

Vaccine Study for Surgically Resected Pancreatic Cancer

NCT00569387

To assess the response for subjects with pancreatic cancer that have undergone surgical resection and treatment with a vaccine given with chemotherapy and chemoradiation.

Pancreatic Cancer

NewLink Genetics Corporation73 participantsStarted Dec 2007

Scottsdale, Arizona, United States • Los Angeles, California, United States • Orange, California, United States +15 more locations

COMPLETEDPhase 3< 1 mile

Immunotherapy Study for Surgically Resected Pancreatic Cancer

NCT01072981

The purpose of this study is to assess overall survival after treatment with a regimen of adjuvant therapy (Gemcitabine alone or with 5-FU chemoradiation) with or without HyperAcute®-Pancreas (algenpantucel-L) immunotherapy in subjects who have undergone surgical resection.

Pancreatic Cancer

NewLink Genetics Corporation722 participantsStarted Apr 2010

Birmingham, Alabama, United States • Mobile, Alabama, United States • Tucson, Arizona, United States +72 more locations

Vaccine Study for Surgically Resected Pancreatic Cancer

Immunotherapy Study for Surgically Resected Pancreatic Cancer

Find Trials by Condition in San Francisco

Transvenous Lead Removal Post-Market Clinical Study

Multimodal Sleep Pathway for Shoulder Arthroplasty

A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP

NFAT-Dependent Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Patients

Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy

Pyruvate Kinase Deficiency Natural History Study

Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas

Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia

Choice of Modality of Follow up for Medication Abortion

A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea

Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)

A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma

Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Pharmacokinetics of Anti-epileptic Drugs in Obese Children

A Phase 3 Substudy to Evaluate Executive Function in Adults With PKU Who Are Participating in the Phase 3 Study, 165-302